Pharmafile Logo
Pharmafocus logo
Advanced Search

AstraZeneca

Showing 15 posts of 785 posts found.

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

December 11, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, COVID-19, Pfizer, Vaccine, pharma, top 10

With just around three weeks until the end of a long year, rapidly emerging news around the leading COVID-19 vaccine …

News
astrazeneca_plaque

AstraZeneca and Oxford Uni vaccine is safe and effective in preventing COVID-19 infection, Phase 3 data show

December 9, 2020
Research and Development AstraZeneca, COVID-19, Vaccine

The latest efficacy data on the COVID-19 vaccine developed by AstraZeneca in partnership with the University of Oxford have been …

News
astrazeneca_sign_sky

NICE recommendation for AstraZeneca’s Calquence in chronic lymphocytic leukaemia populations

December 8, 2020
Manufacturing and Production, Sales and Marketing AstraZeneca, NHS, NICE, UK, leukaemia

The National Institute for Health and Care Excellence (NICE) has recommended that AstraZeneca’s Calquence (acalabrutinib) be used on the NHS in …

News
shutterstock_138095450

Grünenthal buys European rights to AstraZeneca’s Crestor for a potential $350m

December 1, 2020
Manufacturing and Production, Sales and Marketing AstraZeneca, Crestor, Grunenthal

Grünenthal has picked up AstraZeneca’s statin therapy Crestor (rosuvastatin), currently approved in dyslipidaemia and hypercholesterolaemia treatment, in a deal worth …

News
astrazeneca_sign_sky

Japan approves AstraZeneca’s Forxiga for chronic heart failure

November 30, 2020
Sales and Marketing AstraZeneca, Forxiga

Japan’s Ministry of Health, Labour and Welfare (MHLW) has announced the authorisation of AstraZeneca’s Forxiga as a treatment for chronic …

News
astrazeneca_sign_sky

Philippines poised to secure two million AstraZeneca COVID-19 vaccine doses

November 26, 2020
Manufacturing and Production AstraZeneca, COVID-19, Vaccine

The Philippines is set to imminently seal a deal with AstraZeneca for two million doses of AstraZeneca’s COVID-19 vaccine, it …

News
dado_ruvic-illustration-reuters

Interim analysis for AstraZeneca’s COVID-19 vaccine finds 70% average efficacy

November 23, 2020
Research and Development, Sales and Marketing AstraZeneca, COVID-19, Vaccine

Hot on the heels of Moderna and Pfizer/BioNTech who both have released very promising data for their mRNA COVID-19 vaccine …

News
1200px-astrazeneca_hq_in_cambridge_uk

AstraZeneca’s Calquence fails to improve survival rates in coronavirus patients

November 12, 2020
Business Services AZ, AstraZeneca, Calquence

AstraZeneca’s Calquence has failed to improve survival rates and prevent lung failure in patients hospitalised with COVID-19.  Calquence (acalabrutinib) is …

News
astrazeneca_sign_sky

Argentina secures 22 million COVID-19 vaccine doses from AstraZeneca and Oxford Uni

November 9, 2020
Manufacturing and Production, Sales and Marketing Argentina, AstraZeneca, COVID-19, Vaccine

AstraZeneca has committed to an agreement to deliver 22 million doses of its COVID-19 vaccine candidate, co-developed in partnership with …

News
shutter

AstraZeneca’s Brilinta combo reduces rate of disabling stroke or death in stroke patients, according to Phase 3 data

November 9, 2020
Research and Development, Sales and Marketing AstraZeneca, Brilinta, pharma

AstraZeneca has unveiled new Phase 3 data for Brilinta (ticagrelor) as a treatment for patients who have suffered an acute …

News
shutterstock_87495637

AstraZeneca jettisons two heart drugs to Cheplapharm in $400m deal

October 30, 2020
Manufacturing and Production, Medical Communications, Sales and Marketing AstraZeneca, Cheplapharm

AstraZeneca is set to sell the rights to its AT1 subtype angiotensin II receptor antagonist Atacand (candesartan cilexetil) and Atacand …

News
astrazeneca-sign

AstraZeneca’s COVID-19 vaccine generates immune response in both old and young participants

October 26, 2020
Research and Development, Sales and Marketing AstraZeneca, COVID-19, University of Oxford, Vaccine

AstraZeneca’s much-hyped COVID-19 vaccine candidate, AZD1222, currently in development in partnership with the University of Oxford, has shown promising immune …

News
vaccination-1215279_960_720

Spain secures 31.6 million doses of AstraZeneca’s COVID-19 vaccine

October 21, 2020
Manufacturing and Production, Research and Development AstraZeneca, COVID-19, Spain, Vaccine

AstraZeneca continues to forge agreements with national governments to deliver its vaccine against COVID-19, with Spain becoming the latest country …

News
astrazeneca-sign

FDA grants priority review to AstraZeneca’s Tagrisso as an adjuvant for early-stage EGFR-mutated non-small cell lung cancer

October 20, 2020
Manufacturing and Production, Sales and Marketing AstraZeneca, FDA, Tagrisso

The FDA has revealed its decision to grant Priority Review to AstraZeneca’s Tagrisso (osimertinib) as an adjuvant treatment of patients …

News
jnjioffice

European Commission agrees deal with Janssen for 200 million doses of its COVID-19 vaccine

October 9, 2020
Medical Communications AZ, AstraZeneca, Janssen

The European Commission has approved an agreement with Johnson & Johnson for the supply of 200 million doses of Janssen’s …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025